A Multicenter Study to Evaluate Safety, Tolerability, and Clinical Responses of DSP-1083 Into Subjects With Parkinson's Disease
Clinical trial NCT06753331 · RECRUITING
Trial details
- NCT number
- NCT06753331
- Sponsor
- Sumitomo Pharma America, Inc.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-18
- Primary completion
- 2030-12-15
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.